Connect your AI

Integra LifeSciences IART Gross Profit

Gross Profit at other companies

Becton, Dickinson and CompanyBDX

$2.15B+15.7%

StrykerSYK

$3.81B+1.8%

AxogenAXGN

$46.19M+32.2%

AbbVieABBV

$10.78B+15.4%

MedtronicMDT

$6.41B+10.9%

STERISSTE

$697.2M+8.8%

Other financials

Income statement

Revenue$391.9M+2.4%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

Market cap$1.38B-56.8%

Enterprise value$3.12B-26.7%

P/S0.8×-1.1×

Profitability

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

$391.9Mtotal revenue−$174.9Mtotal cost of revenue=$216.98M

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Integra LifeSciences's gross profit?: Integra LifeSciences (IART) reported gross profit of $216.98M in Q1 2026.
How has Integra LifeSciences's gross profit changed year-over-year?: Integra LifeSciences's gross profit increased by 11.6% year-over-year, from $194.43M to $216.98M.
What is the long-term trend for Integra LifeSciences's gross profit?: Over 4 years (2021 to 2025), Integra LifeSciences's gross profit has grown at a -3.1% compound annual growth rate (CAGR), from $944.64M to $831.62M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.